SEC Form 4 · accession 0001415889-19-000107
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon S Saxe
Director
Period of report
Jan 29, 2019
Accepted (ET)
Jan 30, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2019 | M | 375 | $1.50 | A | 2,251 | D | |
| Common Stock | Jan 29, 2019 | M | 1,000 | $1.50 | A | 3,251 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.50 | Jan 29, 2019 | M | 375 | D | Aug 29, 2018 | Mar 24, 2019 | Common Stock | 375 | 0 | D |
| Stock Option (Right to Buy) | $1.50 | Jan 29, 2019 | M | 1,000 | D | Aug 29, 2018 | Nov 4, 2019 | Common Stock | 1,000 | 0 | D |